Global Gilenya Market Size, Share and Trends Analysis Report, By Type (28 Capsules/Box, 96 Capsules/Box), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Others), Forecast (2022-2028)

The global gilenya market is anticipated to grow at a significant CAGR 2% during the forecast period (2022-2028). Market growth is driven mainly by factors such as increased awareness of disruptions such as MS, increased incidence of incidents in developed regions, and a growing population. In addition, the extension of Gilenya’s patent life has also helped to increase revenue for the company that controls the product. The market is also experiencing an increase in the number of generals in Gilenya. This trend, along with the increasing focus on cost-effective medicine, has led to an increase in consumer spending across the globe which will boost revenue growth over the forecast period.

Some major players in the market include Novartis International AG and HEC among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in 2019 the FDA approved the generic form of Gilenya developed by the HEC and approved similar generic products for other companies, but they are now not available in the U.S. market. Generic is a drug that contains the same active ingredients as its brand-name counterparts. It can often help to reduce the cost of treatment by introducing competition in the marketplace.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Novartis, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Gilenya Market Report by Segment

By Type

• 28 Capsules/Box
• 96 Capsules/Box

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Others

Global Gilenya Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa